Drug Profile
Research programme: monoclonal antibody CLN IgG - doxorubicin conjugates
Alternative Names: Monoclonal antibody CLN IgG - doxorubicin conjugates - research programmeLatest Information Update: 26 Apr 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Monoclonal antibodies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Glioma
Most Recent Events
- 08 Feb 2000 New profile
- 08 Feb 2000 Preclinical development for Glioma in Japan (Unknown route)